Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Acquisitions (2012 - 2020)

Grifols' (GIFLF) quarterly Acquisitions came in at -$130.2 million in Q1 2020, up 75.96% on a YoY basis from -$74.0 million in Q2 2019, and up 59.92% quarter-over-quarter from -$324.9 million in Q4 2019.

Analysis

Grifols (GIFLF) Acquisitions (2012 - 2020) Analysis & Trends

Grifols (GIFLF) has reported Acquisitions for 6 consecutive years, with -$130.2 million the latest figure, recorded in Q1 2020.

  • For the quarter ending Q1 2020, Acquisitions rose 75.96% year-over-year to -$130.2 million; the trailing twelve-month figure through Mar 2020 stood at -$615.9 million (down 1380.09% YoY), and the FY2020 full-year result was $2.2 billion, up 763.21% from the prior year.
  • Acquisitions improved to -$130.2 million in Q1 2020 per GIFLF's latest filing, from -$324.9 million in the prior quarter.
  • Across five years, Acquisitions topped out at $381.1 million in Q4 2018 and bottomed at -$541.8 million in Q1 2019.
  • Historically, Acquisitions has averaged -$48.6 million across 4 years, with a median of $21.4 million in 2018.
  • The sharpest annual moves came in 2018 and 2019: Acquisitions jumped 289.95% in 2018, then sank 2629.63% in 2019.
  • Over 4 years, Acquisitions stood at $97.7 million in 2017, then surged by 289.95% to $381.1 million in 2018, then slumped by 185.27% to -$324.9 million in 2019, then soared by 59.92% to -$130.2 million in 2020.
  • According to Business Quant data, Acquisitions over the past three periods registered -$130.2 million, -$324.9 million, and -$541.8 million for Q1 2020, Q4 2019, and Q1 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn -
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 11.21 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn -
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -130.24 Mn
Dec 31, 2019 -324.92 Mn
Mar 31, 2019 -541.80 Mn
Dec 31, 2018 381.05 Mn
Mar 31, 2018 21.42 Mn
Dec 31, 2017 97.72 Mn
Mar 31, 2017 156.72 Mn
Dec 31, 2014 2.75 Mn
Dec 31, 2012 5.23 Mn